Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P479: Trends in medication use and treatment patterns in Chinese patients with Inflammatory Bowel Diseases: A multicenter cohort study from 1999 to 2020ECCO'22
Year: 2022
Authors: Yao, L.(1);Shao, B.(1);Cao, Q.(1);
(1)Sir Run Run Shaw Hospital- College of Medicine Zhejiang University, Department of Gastroenterology, Hangzhou, China;
P480: Comparison of executive functioning profiles among adults with Crohn's disease and Ulcerative colitisECCO'22
Year: 2022
Authors: Zelnik Yovel, D.(1);Meyer, S.(2);Richter, V.(1);Shirin, H.(1);Broide, E.(1);
(1)Shamir Medical center, Gastroenterology, Zerifin, Israel;(2)Ariel University, Faculty of Health Sciences, Ariel, Israel;
P481: profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel diseaseECCO'22
Year: 2022
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);MIranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez, J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celio, C.(12);Alonso Abreu, I.(13);Melcarne, L.(14);Plaza Santos, R.(15);Marques Cami, M.(16);Caballero Mateos, A.(17);Gomez Diez, C.(18);Calafat, M.(19);Alonso Galan, H.(20);Vega Vilaamil, P.(21);Castro Sensosian, B.(22);Guerro Moya, A.(23);Rodriguez Diaz, C.Y.(24);Spicakova, K.(25);Manceñido Marcos, N.(26);Molina, G.(27);De Castro, L.(28);Rodriguez Angulo , A.(29);Cuevas del Campo , L.(30);Rodriguez Grau, M.C.(31);Ramirez, F.(32);Gomez Pastrana, B.(33);Gonzalez Partida, I.(34);Botella Mateu, B.(35);Peña Gonzalez, E.(36);Iyo, E.(37);Elosua Gonzalez , A.(38);Mañosa Ciria, M.(39);Barreiro-De Acosta, M.(40);
(1)Hospital Universitario La Paz, Gastroenterology department. IBD Unit., Madrid, Spain;(2)Hospital Universitario Ramon y Cajal, Gastroenterology Department, Madrid, Spain;(3)Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain;(4)Hospital Clinic de Valencia, Gastroenterology, Valencia, Spain;(5)Hospital universitario clinico de santiago, Gastroenterology, Santiago de Compostela, Spain;(6)Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain;(7)Hospital Gregorio Marañon, Gastroenterology, Madrid, Spain;(8)Hospital Universitario Burgos, Gastroenterology, Burgos, Spain;(9)Hospital Reina Sofia, Gastroenterology, Cordoba, Spain;(10)Hospital universitario Valladolid, Gastroenterology, Valladolid, Spain;(11)Hospital del Mar, Gastroenterology, Barcelona, Spain;(12)Hospital universitario La Princesa, Gastroenterology, Madrid, Spain;(13)Hospital universitario de Canarias, Gastroenterology, Santa Cruz de Tenerife, Spain;(14)Hospital Universitario Parc Taulli Sabadel, Gastroenterology, Barcelona, Spain;(15)Hospital Infanta Leonor, Gastroenterology, Madrid, Spain;(16)Hospital Arnau de Vilanova, Gastroenterology, Lleida, Spain;(17)Hospital Clinic San Cecilio, Gastroenterology, Granada, Spain;(18)Hospital Universitario Cabueñes, Gastroenterology, Gijon, Spain;(19)Hospital Germans Trias i Pujol, Gastroenterology, Badalona, Spain;(20)Hospital universitario de Donostia, Gastroenterology, San Sebastian, Spain;(21)Complexo Hospitalario Universitario de Ourense, Gastroenterologia, Ourense, Spain;(22)Hospital Universitario Marqués de Valdecilla. IDIVAL, Gastroenterology, Santander, Spain;(23)Complexo Hospitalario Universitario A Coruña, Gastroenterology, Coruña, Spain;(24)Hospital Universitario Nuestra Señora de la Candelaria, Gastroenterology, Tenerife, Spain;(25)Hospital Universitario de Alava, Gastroenterology, Vitoria, Spain;(26)Hospital Infanta Sofia, Gastroenterology, Madrid, Spain;(27)Hospital Universitario de Ferrol, Gastroenterology, Coruña, Spain;(28)Hospital Universitario Álvaro Cunqueiro, Gastroenterology, Vigo, Spain;(29)Hospital Universitario de Alicante, Gastroenterology, Alicante, Spain;(30)Getafe University Hospital, Gastroenterology, Madrid, Spain;(31)Hospital del Henares-Coslada, Gastroenterology, Madrid, Spain;(32)Ciudad Real University Hospital, Gastroenterology, Ciudad Real, Spain;(33)General Hospital of Mataro- Maresme-Barcelona, Gastroenterology, Barcelona, Spain;(34)Puerta de Hierro University Hospital. Majadahonda, Gastroenterology, Madrid, Spain;(35)Hospital Univesitario Infanta Cristina-Parla, Gastroenterology, Madrid, Spain;(36)Hospital Royo Villanova, Gastroenterology, Zaragoza, Spain;(37)Hospital Comarcal de Inca, Gastroenterology, Baleares, Spain;(38)Hospital Garcia Orcoyen- Estella, Gastroenterology, Navarra, Spain;(39)Hospital Germans Trias i Pujol-, Gastroenterology, Badalona., Spain;(40)Hospital Universitario Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain;on behalf of the Young Group of GETECCU
P482: Pre-screening IBD patients starting biologic therapies, a positive single centre quality improvement projectECCO'22
Year: 2022
Authors: Colclough, J.(1);Ali, M.(2);Shami, N.(2);Aitchison, L.(2);Hurst, A.(2);Shams-Khan, H.(2);
(1)Wirral University Teaching Hospital, Gastroenterology, Liverpool, United Kingdom;(2)Southport and Ormskirk NHS trust, Gastroenterology, Soutport, United Kingdom;
P483: Patient-reported quality of life, anxiety, and depression associated with switching originator infliximab to biosimilarECCO'22
Year: 2022
Authors: Ritter, T.E.(1);Mehta, S.A.(2);Van Anglen, L.J.(2);
(1)GI Alliance, Research and Education, Southlake- TX, United States;(2)Healix Infusion Therapy, Clinical Research, Sugar Land- TX, United States;
P484: Do vedolizumab trough levels predict response to consecutive therapy in Inflammatory Bowel Disease?ECCO'22
Year: 2022
Authors: Levartovsky, A.(1);Cohen, I.(1);Abitbol, C.M.(1);Yavzori, M.(1);Fudim, E.(1);Picard, O.(1);Kopylov, U.(1);Ben-Horin, S.(1);Ungar, B.(1);
(1)Sheba Medical center, Department of Gastroenterology, Tel Hashomer, Israel;
P485: Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel DiseaseECCO'22
Year: 2022
Authors: Hernandez Camba, A.(1);Carrillo Palau, M.(2);Ramos, L.(2);Alonso, I.(2);Vela, M.(1);Hernández, A.(2);Arranz , L.(1);Hernández, N.(2);Hernández-Guerra, M.(2);Ferráz, I.(3);
(1)Hosp. Universitario Nuestra Señora de la Candelaria, Department of Gastroenterology, Santa Cruz de Tenerife, Spain;(2)Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain;(3)Hospital Universitario de Canarias, Reumatology, La Laguna, Spain;ATEROEII
P486: Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trialsECCO'22
Year: 2022
Authors: Ungaro , R.(1);Siegel , C.A.(2);Cree , B.A.C.(3);Selmaj , K.W.(4,6);Ahmad , H.A.(5);Pai , A.(5);Ather , S.(5);Henry , A.(5);Charles , L.(5);Petersen , A.(5);Cheng , C.Y.(5);Afsari , S.(5);Sheffield , J.(5);Vaile , J.(5);Colombel , J.F.(1);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Dartmouth-Hitchcock Medical Center, Gastroenterology, Lebanon, United States;(3)UCSF MS Center, Neurology, San Francisco, United States;(4)Centrum of Neurology, n/a, Lodz, Poland;(5)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;(6)University of Warmia & Mazury, Department of Neurology, Olsztyn, Poland;
P487: Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)ECCO'22
Year: 2022
Authors: Chaparro, M.(1);Aguas, M.(2);Livne, M.(3);Rivière, P.(4);Bar-Gil Shitrit, A.(5);Myrelid, P.(6);Arroyo, M.(7);Barreiro-de Acosta, M.(8);Bautista, M.(9);Biancone, L.(10);Biron, I.A.(5);Boysen, T.(11);Carpio, D.(12);Castro, B.(13);Dragoni, G.(14);Ellul, P.(15);Holubar, S.D.(16);de Jorge, M.Á.(17);Leo, E.(18);Manceñido, N.(19);Moens, A.(20);Ramírez de la Piscina, P.(21);Ricanek, P.(22);Sebkona, L.(23);Sempere, L.(24);Teich, N.(25);Gisbert, J.P.(1);Julsgaard, M.(26);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Unit, Madrid, Spain;(2)Hospital Universitario y Politécnico La Fe and CIBERehd, Gastroenterology Unit, Valencia, Spain;(3)Sheba Medical Center, Gastroenterology Unit, Tel Hashomer, Israel;(4)Bordeaux University Hospitals, Gastroenterology Unit, Bordeaux, France;(5)Shaare Zedek Medical Center, Gastroenterology Unit, Jerusalem, Israel;(6)Linköping University Hospital and Department of Biomedical and Clinical Sciences- Linköping University, Surgery, Linköping, Sweden;(7)Hospital Clínico Universitario Lozano Blesa- CIBERehd and IIS Aragón, Gastroenterology Unit, Zaragoza, Spain;(8)Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain;(9)Hospital Joan XXIII, Gastroenterology Unit, Tarragona, Spain;(10)University of Rome “Tor Vergata”, Gastroenterology Unit, Rome, Italy;(11)Hvidovre University Hospital, Gastroenterology Unit, Hvidovre, Denmark;(12)Complexo Hospitalario Universitario de Pontevedra- Instituto de Investigación Sanitaria Galicia Sur, Gastroenterology Unit, Pontevedra, Spain;(13)Hospital Universitario Marqués de Valdecilla and IDIVAL, Gastroenterology Unit, Santander, Spain;(14)Careggi University Hospital, Gastroenterology Unit, Florence, Italy;(15)Mater Dei Hospital, Gastroenterology Unit, Msida, Malta;(16)Cleveland Clinic Foundation, Gastroenterology Unit, Cleveland, United States;(17)Hospital de Cabueñes, Gastroenterology Unit, Gijón, Spain;(18)Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain;(19)Hospital Universitario Infanta Sofía, Gastroenterology Unit, San Sebastián de los Reyes, Spain;(20)University hospitals Leuven, Gastroenterology Unit, Leuven, Belgium;(21)Hospital Universitario de Araba sede Txagorritxu y sede Santiago, Gastroenterology Unit, Álava, Spain;(22)Akershus universitetssykehus, Gastroenterology Unit, Ski, Norway;(23)Azieda Opedaliera Pluguiese-Ciaccio, Gastroenterology Unit, Catanzaro, Italy;(24)Hospital General Universitario de Alicante and CIBERehd, Gastroenterology Unit, Alicante, Spain;(25)Practice for internal medicine, Gastroenterology Unit, Leipzig, Germany;(26)Aarhus University Hospital, Gastroenterology Unit, Aarhus, Denmark;on behalf of the ECCO CONFER taskforce
P488: Trends in corticosteroid (CS) use over time and following diagnosis in patients with Inflammatory Bowel Disease (IBD), using IBM® MarketScan®ECCO'22
Year: 2022
Authors: Raine, T.(1);Melmed, G.Y.(2);Finney-Hayward , T.(3);Clark, R.(4);Chapman, J.C.(5);Targownik, L.(6);Burisch, J.(7);Olen, O.(8);
(1)Addenbrooke’s Hospital- Cambridge University Hospitals, Department of Gastroenterology, Cambridge, United Kingdom;(2)Cedars-Sinai, Inflammatory Bowel Disease Center, Los Angeles, United States;(3)AbbVie Ltd., Gastroenterology, Maidenhead, United Kingdom;(4)AbbVie Inc., Research and Development, North Chicago, United States;(5)Texas Digestive Disease Consultants, Gastroenterology, Baton Rouge, United States;(6)Mount Sinai Hospital- University of Toronto, Division of Gastroenterology and Hepatology, Toronto- Ontario, Canada;(7)Hvidovre University Hospital, Gastrounit- Medical Division, Hvidovre, Denmark;(8)Karolinska Institutet, Department of Medicine, Stockholm, Sweden;
P489: Temporal trends of colectomy for ulcerative colitis in the multi-drug era; a population based cohort study.ECCO'22
Year: 2022
Authors: Jenkinson, P.(1);Plevris, N.(1);Lyons, M.(1);Gros, B.(1);Derikx, L.(1);Constantine-Cooke, N.(1);Jones, G.(1);Lees, C.(1);
(1)Edinburgh IBD Unit, Edinburgh IBD Unit, Edinburgh, United Kingdom;
P490: Patients with inflammatory bowel disease should be vaccinated against pneumococcus and influenza despite immunosuppressive therapyECCO'22
Year: 2022
Authors: Dohos, D.(1);Müller, K.E.(1);Sipos, Z.(2);Kiss, S.(2);Dembrovszky, F.(2);Kovács, N.(2);Solymár, M.(2);Erőss, B.(2);Hegyi, P.(2);Sarlós, P.(3);
(1)Heim Pál National Children Hospital, Gastroenterology and Nephrology Department, Budapest, Hungary;(2)University of Pécs, Institute for Translational Medicine, Pécs, Hungary;(3)University of Pécs- Medical School, First Department of Medicine- Division of Gastroenterology, Pécs, Hungary;
P491: Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTEECCO'22
Year: 2022
Authors: FeaganSenior Scientific Officer, B.G.(1,2);Matsuoka, K.(3);Rogler, G.(4);Faes, M.(5);Oortwijn, A.(6);de Haas, A.(6);Rudolph, C.(6);Patel, H.(5);Peyrin-Biroulet, L.(7);
(1)Alimentiv, Inc., London- Ontario, Canada;(2)London Health Sciences Centre- Western University, Division of Gastroenterology, London- Ontario, Canada;(3)Toho University Sakura Medical Center, Department of Gastroenterology and Hepatology, Chiba, Japan;(4)University Hospital Zurich- University of Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland;(5)Galapagos, Nv, Mechelen, Belgium;(6)Galapagos, Nv, Leiden, The Netherlands;(7)University Hospital of Nancy- University of Lorraine, Department of Gastroenterology, Vandoeuvre-lès-Nancy, France;
P492: A comparison of treatment effects for clinical, endoscopic and histological remission in ulcerative colitis clinical trialsECCO'22
Year: 2022
Authors: Sedano, R.(1);Hogan, M.(2);Zou, G.(3);Narula, N.(4);Singh, S.(5);Ma, C.(6);Jairath, V.(7);
(1)Division of Gastroenterology- Department of Medicine- Western University- London- Ontario- Canada/Alimentiv Inc.- London- Ontario- Canada, Department of Medicine- Western University- London- Ontario- Canada, London, Canada;(2)Alimentiv Inc, n/a, London, Canada;(3)Alimentiv Inc., na, London, Canada;(4)Division of Gastroenterology- Department of Medicine Farncombe Family Digestive Health Research Institute- McMaster University- Hamilton- ON- Canada, Division of Gastroenterology- Department of Medicine, Hamilton, Canada;(5)Division of Gastroenterology- University of California San Diego- La Jolla- California- USA, Division of Gastroenterology, San Diego, United States;(6)Division of Gastroenterology & Hepatology- Departments of Medicine and Community Health Sciences- University of Calgary- Calgary- Alberta- Canada, Division of Gastroenterology & Hepatology- Departments of Medicine and Community Health Sciences-, Calgary, Canada;(7)Western University / Alimentiv Inc, Division of Gastroenterology- Department of Medicine- Department of Epidemiology and Biostatistics, London, Canada;
P493: The synthetic glycan KB295 optimises microbiome composition and function in ulcerative colitis: Results from a proof of principle human studyECCO'22
Year: 2022
Authors: Meisner, J.(1);Miller , K.(1);Lee, J.(2);Jose, A.(2);Giuggio, M.(3);McComb , M.(1);Humphries, E.(3);Rosini, M.(4);Wingertzahn, M.(5);Shanahan, F.(6);E.T. van Hylckama Vlieg, J.(7);Dowling , M.(1);
(1)Kaleido Biosciences, Biology, Lexington- MA, United States;(2)Kaleido Biosciences, Computational Biology, Lexington- MA, United States;(3)Kaleido Biosciences, Chemistry, Lexington- MA, United States;(4)Kaleido Biosciences, Chemistry - Technical Operations, Lexington- MA, United States;(5)Kaleido Biosciences, Clinical Development, Lexington- MA, United States;(6)APC Microbiome Ireland, Department of Medicine, University Cork, Ireland;(7)Kaleido Biosciences, Research and Discovery, Lexington- MA, United States;
P494: A serum metabolite panel predicts Crohn’s disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial.ECCO'22
Year: 2022
Authors: Radford-Smith, D.(1);Satsangi, J.(2);Louis, E.(3);Laharie, D.(4);Ding, N.(5);Siegmund, B.(6);D'Haens, G.(7);Erik, H.(8);Yates, A.(9);Anthony, D.(1);Colombel, J.F.(10);Probert, F.(9);
(1)University of Oxford, Pharmacology, Oxford, United Kingdom;(2)University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom;(3)Liège University Hospital, Department of Gastroenterology, Liège, Belgium;(4)Centre Hospitalier Universitaire CHU de Bordeaux, Service d'Hépato-gastroentérologie, Bordeaux, France;(5)Imperial College London, Faculty of Medicine- Department of Surgery & Cancer, London, United Kingdom;(6)Charite Universitatsmedizin Berlin, Medical Department I, Berlin, Germany;(7)Amsterdam University Medical Centers- University of Amsterdam, Gastroenterology, Amsterdam, The Netherlands;(8)Skane University Hospital, Department of Gastroenterology, Lund, Sweden;(9)University of Oxford, Chemistry, Oxford, United Kingdom;(10)The Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;GETAID and the SPARE-Biocycle research group
P495: Perianal fistula closure in patients receiving ustekinumab: Results from the SEAVUE and STARDUST trialsECCO'22
Year: 2022
Authors: Peyrin-Biroulet, L.(1);Panaccione, R.(2);Gasink, C.(3);Hoops, T.(3);Izanec, J.L.(3);Ma, T.(4);Nazar, M.(5);Bravata, I.(6);Lahaye, M.(7);Irving, P.M.(8);Loftus, E.V.(9);Danese, S.(10);Sands, B.E.(11);
(1)Nancy University Hospital, Gastroenterology, Vandœuvre-lès-Nancy, France;(2)University of Calgary, Gastroenterology and Hepatology, Calgary- Alberta, Canada;(3)Janssen, Immunology, Horsham, United States;(4)Janssen, Biostatistics, Horsham, United States;(5)Janssen, Immunology, Warsaw, Poland;(6)Janssen, Immunology, Milan, Italy;(7)Janssen, Biostatistics, Breda, The Netherlands;(8)Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)Mayo Clinic College of Medicine, Gastroenterology and Hepatology, Minnesota, United States;(10)Vita-Salute San Raffaele University, Gastroenterology and Endoscopy, Milan, Italy;(11)Icahn School of Medicine at Mount Sinai, Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;
P496: Efficacy and safety of ustekinumab for chronic antibiotic refractory pouchitis: A Belgian open-label multicentre pilot studyECCO'22
Year: 2022
Authors: Outtier, A.(1);Louis, E.(2);Dewit, O.(3);Schops, G.(1);Verstockt, B.(1);Sabino, J.(1);Vermeire, S.(1);Ferrante, M.(1);
(1)UZ Leuven, Gastroenterology, Leuven, Belgium;(2)CHU Liège- Sart Tilman, Gastroenterology, Liège, Belgium;(3)Cliniques Universitaires Saint-Luc, Gastroenterology, Bruxelles, Belgium;
P497: Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitisECCO'22
Year: 2022
Authors: Sagami, S.(1,2);Kobayashi, T.(1);Aihara, K.(3);Umeda, M.(3);Odajima, K.(3);Morikubo, H.(1,2);Asonuma, K.(1);Miyatani, Y.(1);Fukuda, T.(1,2);Matsubayashi, M.(1,2);Kiyohara, H.(1,2);Nakano, M.(1,2);Hibi, T.(1);
(1)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;(2)Kitasato University Kitasato Institute Hospital, Department of Gastroenterology and Hepatology, Tokyo, Japan;(3)Kitasato University Kitasato Institute Hospital, Department of Clinical Laboratory, Tokyo, Japan;
P498: Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess: The Leeds Steroids studyECCO'22
Year: 2022
Authors: Rosiou, K.(1);Carbonell, J.(1);Dolby, V.(1);Monfared, N.(1);Selinger, C.(1);
(1)Leeds Teaching Hospitals NHS Trust, Gastroenterology, Leeds, United Kingdom;